Seroprevalence of markers of hepatitis C virus exposure and associated factors in adults aged 18-39 years in the Arctic Russian city of Arkhangelsk: a cross-sectional study

References

• Hanafiah KM, Groeger J, Flaxman AD, et al. Global epidemiology of hepatitis C virus infection: new estimates of age–specific antibody to HCV seroprevalence. Hepatology. 2013;57(4):1333–9.
   Web of Science ®Google Scholar
• EASL Clinical Practice. Guidelines. Management of hepatitis C virus infection. J Hepatol. 2014;60:392–420.
   Google Scholar
• World Health Organization [Internet]. Hepatitis C. Key facts. Geneva (Switzerland): World Health Organization; 2018 July 18 [cited 2018 Dec 10]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/hepatitis-c
   Google Scholar
• Heymann DL. Control of communicable diseases manual. In: An official report of the American public health association. 19th ed. Washington (DC): American Public Health Association; 2008. p. 293–295.
   Google Scholar
• Blach S, Zeuzem S, Manns M, et al. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol. 2017;2:161–176. Available from: https://www.thelancet.com/action/showPdf?pii=S2468-1253%2816%2930181-9
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global hepatitis report 2017. Geneva: World Health Organization; 2017.
   Google Scholar
• World Health Organization. Monitoring and evaluation for viral hepatitis B and C: recommended indicators and framework. Geneva: World Health Organization; 2016.
   Google Scholar
• Duffell EF, Hedrich D, Mardh O, et al. Towards elimination of hepatitis B and C in European Union and European economic area countries: monitoring the World Health Organization’s global health sector strategy core indicators and scaling up key interventions. Euro Surveill. 2017;22(9):30476.
   Google Scholar
• Onischenko GG, Zhebrun AB. Viral hepatitis in the Russian Federation. Saint Petersburg: NIIEM Pasteur; 2009. Russian.
   Google Scholar
• Federal Service for Surveillance on Consumer Right Protection and Human Wellbeing. State report “About sanitary and epidemiological wellbeing of population in the Arkhangelsk region in 2018”. Arkhangelsk (Russian Federation): Federal Service for Surveillance on Consumer Right Protection and Human Wellbeing; 2019. Available from: http://29.rospotrebnadzor.ru/dokumenty/doklad/-/asset_publisher/ZdP5/content/государственныи-доклад-«о-состоянии-санитарно-эпидемиологического-благополучия-населения-в-архангельскои-области-в-2018-году»?redirect=http%3A%2F%2F29.rospotrebnadzor.ru%2Fdokumenty%2Fdoklad%3Fp_p_id%3D101_INSTANCE_ZdP5%26p_p_lifecycle%3D0%26p_p_state%3Dnormal%26p_p_mode%3Dview%26p_p_col_id%3Dcolumn-1%26p_p_col_count%3D1. Russian.
   Google Scholar
• Trifonova GF, Levakova IA, Bolsun DD, et al. Acute and chronic hepatitis C in the Russian Federation in 1994–2013. Infect Immun. 2014;4(3):267–274. Russian.
   Google Scholar
• World Health Organization. Global policy report on the prevention and control of viral hepatitis in WHO member states. Geneva (Switzerland); 2013. Available from: http://apps.who.int/iris/bitstream/handle/10665/85397/9789241564632_eng.pdf
   Google Scholar
• Yakusheckina NA. Define the burden of hepatitis C in the Russian Federation and pharmacoeconomic evaluation of new methods to antiviral therapy [dissertation]. Moscow (Russian Federation): Russian national research medical University named after N. And. Pirogov; 2016. Russian.
   Google Scholar
• Soboleva NV, Karlsen AA, Kozhanova TV, et al. The prevalence of the hepatitis C virus among the conditionally healthy population of the Russian population. Zhurnal Infectologii. 2017;9(2):56–64. Russian.
   Google Scholar
• Aasland A, Grønningssæter AB, Mylakhs P, et al. The governance of HIV/AIDS prevention in Northwest Russia: a description of the Norwegian–Russian project. Hum Ecol. 2011;12:49–54. Russian.
   Google Scholar
• Study.com [Internet]. Study.com; c2003–2019. Quota Sampling: Definition, Method & Examples; [cited 2017 Aug 9]; [about 7 screens]. Available from: http://study.com/academy/lesson/quota-sampling-definition-method-examples.html
   Google Scholar
• Balaeva T, Grjibovski AM, Sidorenkov O, et al. Seroprevalence and correlates of herpes simplex virus type 2 infection among young adults in Arkhangelsk, Northwest Russia: a population–based cross–sectional study. BMC Infect Dis. 2016;16(1):616.
   Web of Science ®Google Scholar
• Katz MH. Multivariable analysis. A practical guide for clinicians. Cambridge (UK): Cambridge University Press; 1999. Chapter 3, Setting up a multivariable analysis: subjects; p. 60–83.
   Google Scholar
• Hofstraat SHI, Falla AM, Duffell EF, et al. Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EAA: a systematic review. Epidemiol Infect. 2017;145:2873–2885.
   Web of Science ®Google Scholar
• Annual Report of the Arkhangelsk Office of Federal Service for Surveillance on Consumer Right Protection and Human Wellbeing to the Reference Viral Hepatitis Monitoring Centre of Rospotrebnadzor, 2010–2011. Arkhangelsk (Russian Federation): Arkhangelsk; Arkhangelsk office of the Federal Service for Surveillance of Consumer Rights Protection and Human Wellbeing; 2011. Available at: http://29.rospotrebnadzor.ru/dokumenty/doklad
   Google Scholar
• Reshetnikov OV, Khryanin AA, Teinina TR, et al. Hepatitis B and C seroprevalence in Novosibirsk, western Siberia. Sex Transm Infect. 2001;77:463.
   Web of Science ®Google Scholar
• Yang S, Jiao D, Liu C, et al. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses, and Treponem pallidum infections among blood donors at Shiyan, Central China. BMC Infect Dis. 2016;16:531.
   Web of Science ®Google Scholar
• Moezzi M, Imani R, Karimi A, et al. Hepatitis C seroprevalence and risk factors in adult population of Chaharmahal and Bakhtiari province of Iran in 2013. J Clin Diagn Res. 2015;9(10):Lc13–17.
   Google Scholar
• Hall EW, Rosenberg ES, Sullivan PS. Estimates of state-level chronic hepatitis C virus infection, stratified by race and sex, USA, 2010. BMC Infect Dis. 2018;18:224.
   PubMed Web of Science ®Google Scholar
• Facente SN, Grebe E, Burk K, et al. Estimated hepatitis C prevalence and key population sizes in San Francisco: a foundation for elimination. PLoS ONE. 2018;13(4):e0195575.
   Web of Science ®Google Scholar
• Esmaeili A, Mirzazadeh A, Carter GM, et al. Higher incidence of HCV in females compared to males who inject drugs: a systematic review and meta-analysis. J Viral Hepatitis. 2017;24(2):117–127.
   Web of Science ®Google Scholar
• Grebely J, Larney S, Peacock A, et al. Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs. Addiction. 2019;114(1):150–166. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/add.14393
   Web of Science ®Google Scholar
• Rhodes T, Platt L, Judd A, et al. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia. Int J STD AIDS. 2005;16(11):749–753.
   Web of Science ®Google Scholar
• Alter MJ. Prevention of spread of hepatitis C. Hepatology. 2002;36:S93–98.
   PubMed Web of Science ®Google Scholar
• Rhodes T, Platt L, Maximova S, et al. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study. Addiction. 2006;101:252–266.
   PubMed Web of Science ®Google Scholar
• Abdala N, Carney JM, Durante AJ, et al. Estimating the prevalence of syringe–borne and sexually transmitted diseases among injection drug users in St Petersburg, Russia. Int J STD AIDS. 2003;14:697–703.
   PubMed Web of Science ®Google Scholar
• Onischenko GG, Zhebrun AB. Viral hepatitis in the Russian Federation. Saint Petersburg: NIIEM Pasteur; 2011. Russian.
   Google Scholar
• Turner KM, Hutchinson S, Vickerman P, et al. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction. 2011;106(11):1978–1988.
   PubMed Web of Science ®Google Scholar
• Platt L, Minozzi S, Reed J, et al. Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane review and meta-analysis. Addiction. 2018;113(3):545–563.
   PubMed Web of Science ®Google Scholar
• Ministry of Health of the Arkhangelsk Region. State report “About the public health and health organization in the Arkhangelsk region based on the results of activities during 2017”. Arkhangelsk (Russian Federation): Ministry of Health of the Arkhangelsk Region; 2017. Available from: https://www.minzdrav29.ru/ministry/Open_data/Госдоклад%2027.03.2018%20%20для%20размещения.pdf. Russian.
   Google Scholar
• Ministry of Health of the Russian Federation. Order of the Ministry of Health of the Russian Federation number 364. About Approval of the Procedure of Medical Examination of Donor’s Blood and its Components. Moscow (Russian Federation): Ministry of Health of the Russian Federation; 2001. Russian.
   Google Scholar
• Jindal N, Bansal R, Grover P, et al. Risk factors and genotypes of HCV infected patients attending tertiary care hospital in North India. Indian J Med Microbiol. 2015;33:189–190.
   Web of Science ®Google Scholar
• Huang Y, Guo N, Yu Q, et al. Risk factors for hepatitis B and C infection among blood donors in five Chinese blood centers. Transfusion. 2015;55(2):388–394.
   PubMed Web of Science ®Google Scholar
• Esteban JI, Sauleda S, Quer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol. 2008;48:148–162.
   PubMed Web of Science ®Google Scholar
• HCV epidemiology in the USA [Internet]. Seattlwe (WA): University of Washington; [cited 2018 Dec 11]. Available from: https://www.hepatitisc.uw.edu/go/screening–diagnosis/epidemiology–us/core–concept/all
   Google Scholar
• Chen SL, Morgan TR. The natural history of Hepatitis C Virus (HCV) infection. Int J Med Sci. 2006;3(2):47–52.
   PubMedGoogle Scholar
• Belyakov NA, Konovalova NV, Ogurtsova SV, et al. Is a new wave of HIV spread in the northwest of the Russian Federation a threat or the fact? VICH–infekciya I Immunosupressii. 2016;8(1):73–82. Russian.
   Google Scholar
• Meylakhs P, Aasland A, Gronningseter A. “Until people start dying in droves, no actions will be taken”: perception and experience of HIV-preventive measures among people who inject drugs in Northwestern Russia. Harm Reduct J. 2017;14:33.
   Web of Science ®Google Scholar
• Rhodes T, Sarang A, Vickerman P, et al. Policy resistance to harm reduction for drug users and potential effect of change. BMJ. 2010;341:c3439.
   PubMed Web of Science ®Google Scholar
• Cohen J. Late for the epidemic: HIV/AIDS in Eastern Europe. Science. 2010;329(5988):160:162–164.
   Web of Science ®Google Scholar
• Tor J, Llibre JM, Carbonell M, et al. Sexual transmission of hepatitis C virus and its relation with hepatitis B virus and HIV. Br Med J. 1990;301:1130–1133.
   PubMed Web of Science ®Google Scholar
• Pala CK, Baggio S, Toan TN, et al. Blood–borne and sexually transmitted infections: a cross–sectional study in a Swiss prison. BMC Infect Dis. 2018;18:539.
   Web of Science ®Google Scholar
• Rospotrebnadzor of Russian Federation. Sanitation rules 3.1.5.2826-10 [Prevention of HIV infection]. Moscow (Russian Federation): Rospotrebnadzor; 2010. Russian.
   Google Scholar
• Kholmatova KK, Gorbatova MA, Kharkova OA, et al. Cross-sectional studies: planning, sample size, data analysis. Ekologiya Cheloveka (Human Ecology). 2016;2:49–56. Russian.
   Google Scholar
• Mott DA, Pedersen CA, Doucette WR, et al. A national survey of U.S. pharmacists in 2000: assessing nonresponse bias of a survey methodology. AAPS Pharm Sci. 2001;3:E33.
   Google Scholar